Angiogenesis in Breast Cancer

[1]  J. Farndon,et al.  Synthetic oligonucleotides as therapeutic agents. , 1991, British Journal of Cancer.

[2]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[3]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[4]  A. Yoshimura,et al.  Angiogenic factor , 1992, Nature.

[5]  A. Neville,et al.  Prognostic significance of peritumoral vascular invasion in breast cancer. , 1984, British Journal of Cancer.

[6]  Y. Eto,et al.  Competitive protein binding assay for activin A/EDF using follistatin determination of activin levels in human plasma. , 1992, Biochemical and biophysical research communications.

[7]  H. Thaler,et al.  Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma , 1977, The American journal of surgical pathology.

[8]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[9]  S. Albelda,et al.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.

[10]  A. Goldhirsch,et al.  Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. , 1985, Human pathology.

[11]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[12]  S. Skinner,et al.  Microvascular architecture of experimental colon tumors in the rat. , 1990, Cancer research.

[13]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[14]  G. Westbury,et al.  The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. , 1991, British Journal of Cancer.

[15]  K. Miyazono,et al.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor , 1989, Nature.

[16]  H M Jensen,et al.  Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. , 1982, Science.

[17]  A. Harris,et al.  Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. , 1992, Seminars in cancer biology.

[18]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[19]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[20]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Sutherland.  Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[22]  J. Folkman,et al.  Tumor Behavior in Isolated Perfused Organs: In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment , 1966, Annals of surgery.

[23]  R. Bicknell,et al.  Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. , 1992, Biochemistry.

[24]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[25]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[26]  R Bicknell,et al.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. , 1992, Journal of clinical pathology.

[27]  H. W. Chalkley,et al.  Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .

[28]  J. Denekamp,et al.  Endothelial-cell proliferation in experimental tumours. , 1982, British Journal of Cancer.

[29]  J. Folkman,et al.  Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder , 1980, Annals of surgery.

[30]  D. Gospodarowicz,et al.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. , 1987, Biochemical and biophysical research communications.

[31]  R. Jain,et al.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.

[32]  T. Furukawa,et al.  Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. , 1990, Biochimica et biophysica acta.

[33]  Growth factors and angiogenesis in breast cancer. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[34]  S. McCarthy,et al.  Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. , 1991, Trends in pharmacological sciences.

[35]  R. Fruchter,et al.  The significance of atypical vessels and neovascularization in cervical neoplasia. , 1981, American journal of obstetrics and gynecology.

[36]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[37]  H. Moses,et al.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane , 1990, The Journal of cell biology.

[38]  M. Germain,et al.  Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. , 1977, Journal of the National Cancer Institute.

[39]  A. Harris,et al.  Novel growth regulatory factors and tumour angiogenesis. , 1991, European journal of cancer.

[40]  S. El-Assouli.  The molecular basis for the differential sensitivity of B and T lymphocytes to growth inhibition by thymidine and 5-fluorouracil. , 1985, Leukemia research.

[41]  A. Lee,et al.  Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Pauly,et al.  Elevated Thymidine Phosphorylase Activity in the Plasma and Ascitic Fluids of Tumor-Bearing Animals 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  M. Greenblatt,et al.  Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.